.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,455,533

« Back to Dashboard
Patent 6,455,533 protects CHILDREN'S ZYRTEC ALLERGY and CHILDREN'S ZYRTEC HIVES RELIEF and is included in one NDA.

This patent has twenty-two patent family members in nineteen countries.

Summary for Patent: 6,455,533

Title: Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
Abstract:The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin.
Inventor(s): Fanara; Domenico (Wanze, BE), Berwaer; Monique (Ham-sur-Heure-Nalinnes, BE), Nolf; Philippe (Brussels, BE), Vranckx; Henri (Brussels, BE), Deleers; Michel (Linkebeek, BE)
Assignee: UCB, S.A. (Brussels, BE)
Application Number:09/446,735
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 7th percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
J And J Consumer Inc
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-003Nov 16, 2007DISCNNo6,455,533► subscribeY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
J And J Consumer Inc
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-004Nov 16, 2007DISCNNo6,455,533► subscribeY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
J And J Consumer Inc
CHILDREN'S ZYRTEC HIVES RELIEF
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-005Nov 16, 2007DISCNNo6,455,533► subscribeY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,455,533

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Belgium9700572Jul 03, 1997
PCT Information
PCT FiledJuly 02, 1998PCT Application Number:PCT/BE98/00100
PCT Publication Date:January 14, 1999PCT Publication Number: WO99/01133

International Patent Family for Patent: 6,455,533

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria224717► subscribe
Australia727140► subscribe
Australia8201598► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc